Posts

Saluda Medical Announces $150M Equity Financing Led Wellington Management with Fidelity Management & Research Company and TPG

/in

Financing Further Propels Commercial and Research & Development Initiatives Artarmon, NSW & Bloomington, MN – April 13, 2023, Link here – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the […]

Read more

US FDA clearance of Adherium’s Hailie for Teva inhalers

/in

Adherium receives U.S. FDA 510(k) clearance for Teva’s ProAir® and Albuterol Sulphate inhaler users to remotely monitor physiological parametersMelbourne, Australia – 23 March 2023, Link Here : Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce that it has received U.S. Food and Drug […]

Read more

EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting

/in ,

Artarmon, Australia – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month Study received the Outstanding Achievement in Research Award at the 25th annual meeting of the American Society of Interventional Pain Physicians (ASIPP) in National Harbor, MD. The plenary session presentation titled […]

Read more

Humanetix and The Home Caring Group team up for care platform project

/in

The software vendor will work with Home Caring’s subsidiary Sygnal Technology. Sasha Karen (ARN) 23 January 2023 15:56, Link Here:Software vendor Humanetix has scored a deal with The Home Caring Group to roll out its health care-focused platform ACE for 4,500 customers, as well as fuse both parties’ technology offerings.Home Caring provides a range of […]

Read more

Adherium receives Australian TGA approval for Next Generation Sensors

/in

Melbourne, Australia – Link Here: Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce receiving Australian Therapeutic Goods Administration (TGA) approval to commercially distribute its new, next generation Hailie® sensors with physiological parameters. These latest additions to the Hailie sensor product family connect patients […]

Read more

Canary Medical named a 2023 BIG Innovation Award Winner for Healthcare

/in

11 EXECUTIVES, 55 COMPANIES AND 91 PRODUCTS WIN 2023 BIG INNOVATION AWARD BUSINESS INTELLIGENCE GROUP ANNOUNCES THE WINNERS OF THE 2023 BIG INNOVATION AWARDS Philadelphia, PA— Link Here —Today, the Business Intelligence Group named 11 executives, 55 companies, and 91 products as leaders and winners of the 2023 BIG Innovation Awards. This annual business awards […]

Read more

Adherium receives U.S. FDA 510(k) clearance for GSK pMDI inhaler users to remotely monitor physiological parameters

/in

Melbourne, Australia – 28 November 2022: (Link Here) Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that is has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market application, connecting GlaxoSmithKline’s (GSK) Ventolin®, Advair®, and Flovent® pressurised metered dose inhaler (pMDI) users with […]

Read more

Clinical Study involving new Hailie Sensor with Physiological Parameters Launched in U.S.

/in

Melbourne, Australia – 20 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce a two-part clinical study at Washington University School of Medicine in St. Louis in the United States to monitor the adherence of Asthma patients using Adherium’s US […]

Read more

Adherium secures A$13.5 million commitment in share and option placement

/in

Melbourne, Australia Link Here – 16 September 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments from the Company’s Chairman, new and existing institutional and sophisticated investors, including cornerstone investments from existing shareholders Trudell Medical and BioScience Managers Translation Fund […]

Read more

Adherium and CareCentra Team Up to Develop a Respiratory Risk Management System

/in

Melbourne, Australia Link Here – 13 September 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce a platform partnership with CareCentra Inc. to improve COPD (Chronic Obstructive Pulmonary Disease) and Asthma care creating a truly transformative disease management suite. CareCentra will integrate Adherium’s […]

Read more